FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

347340000: Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3693356010 Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3693357018 Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel en Synonym Active Entire term case insensitive SNOMED CT core module
46793201000001119 Salicylic acid 2% / Mucopolysaccharide polysulphate 0.2% gel en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module
75148701000001114 Salicylic acid 2% / Mucopolysaccharide polysulfate 0.2% gel en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module


6 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Is a Salicylic acid product false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Is a Salicylic acid gel false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has active ingredient Keratolytic agent false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has active ingredient Salicylic acid false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Is a Product containing heparinoid false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Is a Product containing salicylic acid false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has active ingredient Heparinoid false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has active ingredient Topical agent false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has manufactured dose form Gel false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Is a Product containing salicylic acid in topical dosage form false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has manufactured dose form Conventional release cutaneous gel false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has concentration strength numerator unit milligram true Inferred relationship Existential restriction modifier 2
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has concentration strength denominator unit gram true Inferred relationship Existential restriction modifier 1
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has precise active ingredient Heparinoid false Inferred relationship Existential restriction modifier 2
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has basis of strength substance Heparinoid false Inferred relationship Existential restriction modifier 2
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has concentration strength denominator unit gram true Inferred relationship Existential restriction modifier 2
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has concentration strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has concentration strength numerator value 2 false Inferred relationship Existential restriction modifier 2
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has precise active ingredient Salicylic acid false Inferred relationship Existential restriction modifier 1
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has basis of strength substance Salicylic acid false Inferred relationship Existential restriction modifier 1
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has concentration strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has concentration strength denominator value 1 false Inferred relationship Existential restriction modifier 2
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has concentration strength numerator value 20 false Inferred relationship Existential restriction modifier 1
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Is a Product containing only heparinoid and salicylic acid in cutaneous dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Plays role Antifungal therapeutic role true Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has precise active ingredient Heparinoid true Inferred relationship Existential restriction modifier 1
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has basis of strength substance Heparinoid true Inferred relationship Existential restriction modifier 1
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has precise active ingredient Salicylic acid true Inferred relationship Existential restriction modifier 2
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has basis of strength substance Salicylic acid true Inferred relationship Existential restriction modifier 2
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Plays role Antivaricose therapeutic role true Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has manufactured dose form Cutaneous dose form true Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has active ingredient Salicylate false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has manufactured dose form Conventional release cutaneous gel false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has NHS dm+d (dictionary of medicines and devices) dose form indicator Continuous dose form indicator true Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route gel.cutaneous ontology form and route true Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Topical route false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has active ingredient Salicylic acid false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Cutaneous true Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has active ingredient Mucopolysaccharide polysulphate false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has manufactured dose form Gel false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has manufactured dose form Conventional release cutaneous gel false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has active ingredient Heparinoid false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has manufactured dose form Conventional release cutaneous gel false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has specific active ingredient Mucopolysaccharide polysulfate true Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has manufactured dose form Gel false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has manufactured dose form Gel false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has specific active ingredient Salicylic acid true Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has specific active ingredient Mucopolysaccharide polysulphate false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has dispensed dose form Gel true Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Is a Mucopolysaccharide polysulphate + Salicylic acid true Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has specific active ingredient Mucopolysaccharide polysulfate false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has specific active ingredient Heparinoid false Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Has specific active ingredient Mucopolysaccharide polysulphate false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Heparinoid+salicylic acid 0.2%/2% gel - product Is a False Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Inferred relationship Existential restriction modifier
Movelat gel (Sankyo Pharma UK) Is a True Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Inferred relationship Existential restriction modifier
Movelat Relief gel (Sankyo Pharma UK) Is a True Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Inferred relationship Existential restriction modifier
Salicylic acid 2% / Mucopolysaccharide polysulphate 0.2% gel 80 gram Is pack of False Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Inferred relationship Existential restriction modifier
Salicylic acid 2% / Mucopolysaccharide polysulphate 0.2% gel 40 gram Is pack of False Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Inferred relationship Existential restriction modifier
Salicylic acid 2% / Mucopolysaccharide polysulphate 0.2% gel 100 gram Is pack of False Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Inferred relationship Existential restriction modifier
Movelat gel (PI) (Dowelhurst Ltd) Is a True Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Inferred relationship Existential restriction modifier
Salicylic acid 2% / Mucopolysaccharide polysulphate 0.2% gel 120 gram Is pack of False Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Inferred relationship Existential restriction modifier
Movelat gel (PI) (Waymade Ltd) Is a True Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Inferred relationship Existential restriction modifier
Salicylic acid 2% / Mucopolysaccharide polysulphate 0.2% gel 40 gram Has VMP True Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Inferred relationship Existential restriction modifier
Salicylic acid 2% / Mucopolysaccharide polysulphate 0.2% gel 80 gram Has VMP True Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Inferred relationship Existential restriction modifier
Salicylic acid 2% / Mucopolysaccharide polysulphate 0.2% gel 120 gram Has VMP True Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Inferred relationship Existential restriction modifier
Salicylic acid 2% / Mucopolysaccharide polysulphate 0.2% gel 100 gram Has VMP True Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Inferred relationship Existential restriction modifier
Movelat gel (Necessity Supplies Ltd) Is a True Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Inferred relationship Existential restriction modifier
Salicylic acid 2% / Mucopolysaccharide polysulphate 0.2% gel 125 gram Has VMP True Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Inferred relationship Existential restriction modifier
Movelat gel (Lexon (UK) Ltd) Is a True Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Inferred relationship Existential restriction modifier
Salicylic acid 2% / Mucopolysaccharide polysulphate 0.2% gel (J M McGill Ltd) Is a False Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start